Hemophilia A Clinical Trials in Seattle, Washington
4 recruitingSeattle, Washington
Showing 1–4 of 4 trials
Recruiting
Phase 3
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
Hemophilia AHemophilia B
Pfizer173 enrolled17 locationsNCT05568719
Recruiting
Phase 3
Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
Hemophilia AHemophilia B
Pfizer245 enrolled75 locationsNCT05145127
Recruiting
Hemophilia A Research Program
PregnancyHemophilia APregnancy Complications+10 more
University of Washington500 enrolled1 locationNCT07414511
Recruiting
Effects of Emicizumab vs. Factor VIII Prophylaxis on Joint and Bone Health in Severe Hemophilia A
Hemophilia A
Washington Institute for Coagulation40 enrolled4 locationsNCT04131036